More articles from From the Editor
- Unproven therapies and media hype
We should be wary of unproven treatments that may he worse than the disease.
- Rare but serious adverse effects in commonly used drugs
Some adverse effects come to light only after millions of people have taken a drug.
- New findings in multiple sclerosis: A message for primary care clinicians
Every once in a while, a new finding transforms the diagnosis and treatment of a disease.
- Addressing both sides of a difficult controversy
Should a promising technology be widely applied before the data are in?
- Fly-fishing and painting inspire CCJM Art Director’s Homeric odyssey
Artist, biographer, and fisherman—Bob Demarest, our Art Director, is a man of many talents.
- The return of The Clinical Picture
Sharpen your powers of observation with our revived question-and-answer quiz.
- What’s your opinion of CCJM’s Patient Information page?
Is our Patient Information page useful “as is,” or are changes in order? Let us know.
- Louisa Paskert, aide to five CCJM editors, to retire after 34 years
As our editorial assistant, Louisa contributesto every aspect of the Journal.
- Drug-related topics selected for relevance to patient care
Our goal is to keep you informed of developments that are changing the practice of medicine.